GlassScriptPhysician profile
Andrew R Duffee
NPI 1811029580
$12,786.90
in general payments reported to CMS, 2019-2025
40 companies · $1,825 in 2025
The $1,825 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,963 · 2020: $1,039 · 2021: $2,616 · 2022: $2,797 · 2023: $1,013 · 2024: $536 · 2025: $1,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,742.05 | 2019-2025 | Comprehensive Shoulder System, Persona, Oxford |
| Depuy Synthes Sales INC. | $2,555.07 | 2019-2025 | Dynacord, Healix Knotless Peek, Na |
| Stryker Corporation | $1,050.49 | 2019-2025 | Reunion, Axsos, Iconix |
| Alpha Orthopedic Systems | $960.90 | 2019-2023 | |
| Wright Medical Technology, INC. | $699.00 | 2019 | |
| Pacira Therapeutics, INC. | $597.85 | 2019-2021 | |
| Medartis INC. | $501.96 | 2020-2022 | |
| Depuy Synthes Products, INC. | $450.00 | 2021 | |
| Smith+Nephew, INC. | $375.24 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame, Accu-Pass |
| Linvatec Corporation | $161.75 | 2023 | Biobrace 23mm |
| Osteocentric Technologies, INC. | $150.00 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Pacira Pharmaceuticals Incorporated | $144.25 | 2019-2025 | Zilretta, Exparel |
| Encore Medical, LP | $129.87 | 2021 | |
| Dynasplint Systems INC. | $128.75 | 2021-2023 | Dynasplint |
| Medical Device Business Services, INC. | $99.99 | 2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $91.96 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $88.82 | 2025 | |
| Medacta USA, INC. | $79.90 | 2024-2025 | Nextar Rsa Platform |
| Wound Management Technologies, INC | $70.59 | 2019 | |
| Vericel Corporation | $66.61 | 2019-2022 | |
| Bioventus LLC | $60.05 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Endo Pharmaceuticals INC. | $54.61 | 2019-2022 | |
| Acumed LLC | $42.68 | 2022 | |
| Amgen INC. | $40.70 | 2024-2025 | Prolia, Evenity |
| Convatec INC. | $39.83 | 2022-2025 | |
| Ethicon US, LLC | $39.67 | 2025 | Ethicon, Stratafix |
| Organogenesis INC. | $39.39 | 2025 | Apligraf |
| Sanofi-Aventis U.S. LLC | $38.26 | 2019-2021 | |
| Heraeus Medical, LLC. | $37.57 | 2021-2022 | |
| Orthofix Medical, INC. | $33.82 | 2019-2024 | Physio-Stim |
| Kerecis Limited | $32.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kowa Pharmaceuticals America, INC. | $29.73 | 2022 | |
| Blue Surgical LLC | $25.37 | 2025 | |
| Ermi LLC | $23.31 | 2023 | |
| Ferring Pharmaceuticals INC. | $22.63 | 2019 | |
| Polynovo North America LLC | $21.97 | 2024 | Novosorb Btm |
| Sanara Medtech INC. | $18.98 | 2020 | |
| Precision Medical Products INC. | $16.34 | 2021 | |
| Avanos Medical | $12.30 | 2019 | |
| Kci USA, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Duffee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.